[go: up one dir, main page]

MX2022011245A - Método de generación de células hepáticas. - Google Patents

Método de generación de células hepáticas.

Info

Publication number
MX2022011245A
MX2022011245A MX2022011245A MX2022011245A MX2022011245A MX 2022011245 A MX2022011245 A MX 2022011245A MX 2022011245 A MX2022011245 A MX 2022011245A MX 2022011245 A MX2022011245 A MX 2022011245A MX 2022011245 A MX2022011245 A MX 2022011245A
Authority
MX
Mexico
Prior art keywords
hepatic cells
generating
generating hepatic
methods
cells
Prior art date
Application number
MX2022011245A
Other languages
English (en)
Inventor
Tüzer Kalkan
Thomas Pierre Michel Moreau
Carl Ward
Tildon Grant Belgard
Fabian Bachinger
Original Assignee
Bit Bio Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bit Bio Ltd filed Critical Bit Bio Ltd
Priority claimed from PCT/GB2021/050622 external-priority patent/WO2021181110A1/en
Publication of MX2022011245A publication Critical patent/MX2022011245A/es

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/067—Hepatocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/37—Digestive system
    • A61K35/407—Liver; Hepatocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0696—Artificially induced pluripotent stem cells, e.g. iPS
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/025—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6881—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for tissue or cell typing, e.g. human leukocyte antigen [HLA] probes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/60—Transcription factors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2503/00—Use of cells in diagnostics
    • C12N2503/02—Drug screening
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
    • C12N2506/02—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from embryonic cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
    • C12N2506/03—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from non-embryonic pluripotent stem cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
    • C12N2506/45—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from artificially induced pluripotent stem cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5067—Liver cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Developmental Biology & Embryology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Virology (AREA)
  • Analytical Chemistry (AREA)
  • Nutrition Science (AREA)
  • Epidemiology (AREA)
  • Physics & Mathematics (AREA)
  • Physiology (AREA)
  • Biophysics (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Transplantation (AREA)
  • Toxicology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)

Abstract

La invención se refiere a métodos de generación de células hepáticas mediante la sobre-expresión de combinaciones de factores de transcripción, en particular para usarse en métodos de reprogramación celular.
MX2022011245A 2020-03-11 2021-03-11 Método de generación de células hepáticas. MX2022011245A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202062988349P 2020-03-11 2020-03-11
PCT/GB2021/050622 WO2021181110A1 (en) 2020-03-11 2021-03-11 Method of generating hepatic cells

Publications (1)

Publication Number Publication Date
MX2022011245A true MX2022011245A (es) 2023-01-11

Family

ID=77663668

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2022011245A MX2022011245A (es) 2020-03-11 2021-03-11 Método de generación de células hepáticas.

Country Status (9)

Country Link
US (2) US11274279B2 (es)
EP (1) EP4118188A1 (es)
JP (1) JP2023516484A (es)
KR (1) KR20230010625A (es)
CN (1) CN115551994A (es)
AU (1) AU2021235252A1 (es)
BR (1) BR112022018092A2 (es)
CA (1) CA3175071A1 (es)
MX (1) MX2022011245A (es)

Family Cites Families (144)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5837234A (en) 1995-06-07 1998-11-17 Cytotherapeutics, Inc. Bioartificial organ containing cells encapsulated in a permselective polyether suflfone membrane
WO2002064748A2 (en) 2001-02-14 2002-08-22 Furcht Leo T Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof
NZ337792A (en) 1999-09-14 2002-03-28 Pastoral Agric Res Inst Nz Ltd Nuclear transfer and use in cloning
US20030082155A1 (en) 1999-12-06 2003-05-01 Habener Joel F. Stem cells of the islets of langerhans and their use in treating diabetes mellitus
US7544509B2 (en) 2000-01-24 2009-06-09 Mcgill University Method for preparing stem cell preparations
WO2001059076A2 (en) 2000-02-09 2001-08-16 The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Premeiotic and postmeiotic origin of teratomas: isolated teratoma stem cells for therapeutic uses
US7473555B2 (en) 2000-04-27 2009-01-06 Geron Corporation Protocols for making hepatocytes from embryonic stem cells
WO2002073188A1 (en) 2001-03-13 2002-09-19 Advanced Cell Technology, Inc. Method for generating replacement cells and/or tissues
US6582955B2 (en) 2001-05-11 2003-06-24 Spectrum Laboratories, Inc. Bioreactor with application as blood therapy device
EP1404816B1 (fr) 2001-07-06 2010-02-17 Institut National De La Sante Et De La Recherche Medicale (Inserm) Lignees d'hepatomes humains leurs obtention et leurs applications
WO2003023019A1 (en) 2001-09-07 2003-03-20 Fox Chase Cancer Center Methods and cell cultures for promoting organogenesis and tissue development
AU2002363659B2 (en) 2001-11-15 2008-09-25 Children's Medical Center Corporation Methods of isolation, expansion and differentiation of fetal stem cells from chorionic villus, amniotic fluid, and placenta and therapeutic uses thereof
TWI288779B (en) 2002-03-28 2007-10-21 Blasticon Biotech Forschung Dedifferentiated, programmable stem cells of monocytic origin, and their production and use
AUPS187202A0 (en) 2002-04-22 2002-05-30 Griffith University Method for culturing stem cells
WO2004007683A2 (en) 2002-07-15 2004-01-22 Massachusetts Institute Of Technology Cellular reprogramming in peptide hydrogel and uses thereof
WO2004046310A2 (en) 2002-11-15 2004-06-03 Five Prime Therapeutics, Inc. Novel mouse polypeptides encoded by polynucleotides and methods of their use
US8148152B2 (en) 2003-07-08 2012-04-03 Axiogenesis Ag Method for the preparation of embryoid bodies (EBs) and uses thereof
EP1516924A1 (en) 2003-09-17 2005-03-23 Fundacion IVI para el Estudio de la reproduccion Humana (FIVIER) Generation of human embryonic stem cells from triploid zygotes
EP1516925A1 (en) 2003-09-18 2005-03-23 Fundacion IVI para el Estudio de la reproduccion Humana (FIVIER) Generation of human embryonic stem cells from triploid zygotes
WO2005040391A1 (en) 2003-10-27 2005-05-06 Murdoch Childrens Research Institute Compositions and methods for differentiating stem cells
ATE493492T1 (de) 2003-11-04 2011-01-15 Biomaster Inc Verfahren und system zur herstellung von stammzellen aus fettgewebe
GB0329449D0 (en) 2003-12-19 2004-01-28 Omnicyte Ltd Stem cells
JP5588587B2 (ja) 2004-01-14 2014-09-10 ノーバヘップ アーベー ヒトの肝臓前駆細胞およびその使用方法
EP1576957A1 (en) 2004-03-18 2005-09-21 Universiteit Twente Tissue repair using pluripotent cells
WO2005097980A2 (en) 2004-03-26 2005-10-20 Geron Corporation New protocols for making hepatocytes from embryonic stem cells
EP1600500A1 (en) 2004-05-27 2005-11-30 Georg-August-Universität Göttingen Method for producing pluripotent cells from monocytes
KR20060089774A (ko) 2005-02-04 2006-08-09 재단법인서울대학교산학협력재단 서로 다른 개체로부터 유래된 체세포와 난자로부터 유래된 인간 배아 줄기세포 및 그 제조방법
WO2006126219A1 (en) 2005-05-26 2006-11-30 Fresenius Medical Care Deutschland G.M.B.H. Liver progenitor cells
WO2006131543A1 (en) 2005-06-09 2006-12-14 Artemis Pharmaceuticals Gmbh Shrna and sirna expression in a living organism under control op a codon-optimized tetracycline repressor gene
WO2007002228A1 (en) 2005-06-23 2007-01-04 Massachusetts Institute Of Technology Methods for ex vivo propagation of adult hepatic stem cells
KR20080033455A (ko) 2005-07-26 2008-04-16 상가모 바이오사이언스 인코포레이티드 외래 핵산 서열의 표적화된 통합 및 발현
AU2006325975B2 (en) 2005-12-13 2011-12-08 Kyoto University Nuclear reprogramming factor
ES2672205T3 (es) 2005-12-21 2018-06-13 Université Catholique de Louvain Células madre hepáticas aisladas
GB2453074B (en) 2006-06-02 2011-06-22 Geron Corp Differentiation of primate pluripotent cells to hepatocyte-lineage cells
ITMI20061772A1 (it) 2006-09-18 2008-03-19 Consiglio Nazionale Ricerche Procedimento per la preparazione di cellule epatiche da cellule progenitrici presenti nel sangue di cordone ombelicale
WO2008060792A2 (en) 2006-10-12 2008-05-22 Stem Cells Innovations Novel cells, compositions, and methods
US8835163B2 (en) 2006-10-18 2014-09-16 The Board Of Trustees Of The University Of Illinois Embryonic-like stem cells derived from adult human peripheral blood and methods of use
EP2118278A4 (en) 2007-01-19 2010-04-14 Sinai School Medicine TARGETED GENE MODIFICATION OF STEM CELLS
EP2607477B1 (en) 2007-05-03 2020-09-23 The Brigham and Women's Hospital, Inc. Multipotent stem cells and uses thereof
US8309353B2 (en) 2007-05-30 2012-11-13 Kumamoto University Method for induction of differentiation of ES cell
EP2172541A4 (en) 2007-06-14 2010-06-30 Found Biomedical Res & Innov METHOD FOR PRODUCING A LIVER SURFACE-SIMILAR CELL MASK FROM A CELL GENERATING FROM FAT TISSUE
US9213999B2 (en) 2007-06-15 2015-12-15 Kyoto University Providing iPSCs to a customer
GB2450761B (en) 2007-07-06 2010-08-04 Univ London Multi-functional chamber for housing a biological component
WO2009080794A1 (en) 2007-12-21 2009-07-02 Mc2 Cell Aps Method for preparing cell-specific extracellular matrices
WO2010007031A2 (en) 2008-07-14 2010-01-21 Novartis Ag Methods for improving cardiac differentiation of human embryonic stem cells
EP2362899A1 (en) 2008-10-31 2011-09-07 Katholieke Universiteit Leuven Optimized methods for differentiation of cells into cells with hepatocyte and hepatocyte progenitor phenotypes, cells produced by the methods, and methods for using the cells
EP2356213B1 (en) 2008-11-04 2019-05-29 Viacyte, Inc. Stem cell aggregate suspension compositions and methods for differentiation thereof
CA2745742A1 (en) 2008-12-03 2010-06-10 International Stem Cell Corporation Methods of deriving differentiated cells from stem cells
CN101748096B (zh) 2008-12-17 2013-03-13 北京汉氏联合生物技术有限公司 亚全能干细胞、其制备方法及其用途
EP2412800A1 (en) 2010-07-29 2012-02-01 Koninklijke Nederlandse Akademie van Wetenschappen Liver organoid, uses thereof and culture method for obtaining them
GB0905331D0 (en) 2009-03-27 2009-05-13 Avecia Biolog Ltd Expression process
WO2010117464A1 (en) 2009-04-09 2010-10-14 Sangamo Biosciences, Inc. Targeted integration into stem cells
EP2421954B1 (en) 2009-04-21 2018-12-26 Academisch Ziekenhuis bij de Universiteit van Amsterdam Differentiated human liver cell cultures and their use in bioartificial liver systems
EP2253700A1 (en) 2009-05-13 2010-11-24 Helmholtz-Zentrum für Infektionsforschung GmbH A method for producing test systems from donors suffering from adverse effects of medicaments and /or medical treatments, and uses of said systems
CN102762718B (zh) 2009-10-13 2015-06-17 干细胞技术公司 用于分化干细胞的重量克分子渗透压浓度控制
EP2495320B1 (en) 2009-10-28 2019-02-27 Japan Health Sciences Foundation Method for induction of differentiation of stem cells into hepatocytes
WO2011084747A2 (en) 2009-12-21 2011-07-14 The Johns Hopkins University Compositions and methods for somatic tissue induced pluripotent stem cells having an endoderm origin
EP2550355B1 (en) 2010-03-22 2016-11-16 Takara Bio Europe AB Directed differentiation and maturation of pluripotent cells into hepatocyte like cells by modulation of wnt-signalling pathway
EP2551341B1 (en) 2010-03-23 2017-04-26 Kuraray Co., Ltd. Culture method for causing differentiation of pluripotent mammalian cells
WO2011119942A1 (en) 2010-03-25 2011-09-29 Vistagen Therapeutics, Inc. Induction of ips cells using transient episomal vectors
JP5968871B2 (ja) * 2010-04-13 2016-08-10 セルラー ダイナミクス インターナショナル， インコーポレイテッド フォワードプログラミングによる肝細胞の産生
EP2588592B1 (en) 2010-06-30 2017-09-06 Miromatrix Medical Inc. Use of perfusion decellularized organs for matched recellularization
WO2012005690A1 (en) 2010-07-07 2012-01-12 Massachusetts Institute Of Technology Methods of reconstituting human hepatocytes and human hematopoietic cells in non-human mammals
EP2601289B1 (en) 2010-08-04 2017-07-12 Cellular Dynamics International, Inc. Reprogramming immortalized b cells
GB201014169D0 (en) 2010-08-25 2010-10-06 Cambridge Entpr Ltd In vitro hepatic differentiation
US9181529B2 (en) 2010-10-19 2015-11-10 Cellular Dynamics International, Inc. Titration of differentiation medium components
JP5938726B2 (ja) 2010-10-28 2016-06-22 国立大学法人 熊本大学 多能性幹細胞の分化誘導効率を改善するための方法及び培地
US9555061B2 (en) 2011-04-15 2017-01-31 National University Corporation Torrori University Synthesis and analysis of compounds capable of inducing differentiation of human mesenchymal stems cells into hepatocytes
CA2833173C (en) 2011-04-20 2023-09-05 University Of Washington Through Its Center For Commercialization Beta-2 microglobulin-deficient cells
WO2013062140A1 (en) 2011-10-28 2013-05-02 Kyoto University Method for efficiently inducing differentiation of pluripotent stem cells into hepatic lineage cells
GB201119335D0 (en) 2011-11-09 2011-12-21 Univ Leuven Kath Hepatitis virus infectable stem cells
BR112014020089A2 (pt) 2012-02-15 2017-07-04 Mice With Horns Llc animais transgênicos com características que podem ser customizadas
EP2836591B1 (en) 2012-04-09 2018-06-06 The United States of America, as represented by The Secretary, Department of Health and Human Services Methods for generation of pluripotent and multipotent cells
AU2012202353B2 (en) 2012-04-20 2015-01-15 Medela Holding Ag Stem cell preparations and methods of use
WO2013189521A1 (en) 2012-06-19 2013-12-27 Waclawczyk Simon Method of generating cells of hepatocyte phenotype
GB201212111D0 (en) 2012-07-06 2012-08-22 Gmbh Vascular bed-specific endothelial cells
WO2014053709A1 (en) 2012-10-05 2014-04-10 Glykos Finland Oy A method for culturing stem cells
EP3401391A1 (en) 2012-11-29 2018-11-14 Takara Bio Europe AB Maturation of hepatocyte-like cells derived from human pluripotent stem cells
CN103981147B (zh) 2013-02-08 2017-11-10 中国科学院上海生命科学研究院 一种新的制备肝实质细胞的方法
US10913933B2 (en) 2013-02-13 2021-02-09 Wake Forest University Health Sciences Bioengineered liver constructs and methods relating thereto
KR101767802B1 (ko) 2013-03-15 2017-08-11 에프. 호프만-라 로슈 아게 줄기세포를 간세포로 개선되게 분화시키기 위한 화합물
WO2014144125A1 (en) 2013-03-15 2014-09-18 The Broad Institute, Inc. Compounds for inducing proliferation and differentiation of cells, and methods of use thereof
WO2014153346A1 (en) 2013-03-18 2014-09-25 Massachusetts Institute Of Technology Engineering a heterogeneous tissue pluripotent stem cells
JP6473686B2 (ja) 2013-03-25 2019-02-20 公益財団法人神戸医療産業都市推進機構 細胞の選別方法
GB201307486D0 (en) 2013-04-25 2013-06-12 Cambridge Entpr Ltd Cell-cycle directed differentiation of pluripotent cells
SG10201914005TA (en) 2013-09-19 2020-03-30 Univ Leland Stanford Junior Methods and compositions for producing hepatocyte-like cells
GB201317869D0 (en) 2013-10-09 2013-11-20 Cambridge Entpr Ltd In vitro production of foregut stem cells
KR101542849B1 (ko) 2013-11-01 2015-08-10 주식회사 비비에이치씨 중간엽 줄기세포로부터 유도된 만능 줄기세포를 이용하여 간세포로 분화시키는 방법
WO2015073751A1 (en) 2013-11-15 2015-05-21 Applied Stemcell, Inc. Methods for isolating lineage-specific cells
EP3088415B1 (en) 2013-12-25 2019-11-06 Toagosei Co., Ltd. Method for inducing differentiation of pluripotent stem cells into endodermal cells
US10266806B2 (en) 2014-01-14 2019-04-23 Colorado State University Research Foundation Stem cell-derived hepatocytes in co-culture and uses thereof
JP6791756B2 (ja) 2014-01-21 2020-11-25 ザ メディカル カレッジ オブ ウィスコンシン インクＴｈｅ Ｍｅｄｉｃａｌ Ｃｏｌｌｅｇｅ Ｏｆ Ｗｉｓｃｏｎｓｉｎ， Ｉｎｃ． 多能性幹細胞の選択的な阻害のための方法
CN104830906B (zh) 2014-02-12 2018-09-04 北京维通达生物技术有限公司 一种重编程获得功能性人肝脏实质细胞的方法
EP3119879B1 (en) 2014-03-19 2019-12-25 INSERM (Institut National de la Santé et de la Recherche Médicale) A method for inducing human cholangiocyte differentiation
WO2015164228A1 (en) 2014-04-21 2015-10-29 Cellular Dynamics International, Inc. Hepatocyte production via forward programming by combined genetic and chemical engineering
GB201409858D0 (en) 2014-06-03 2014-07-16 Ucl Business Plc Human liver scaffolds
KR101535070B1 (ko) 2014-07-16 2015-07-10 서울대학교산학협력단 혈관성장인자 유전자의 형질전환을 위한 재조합 발현 벡터 및 이를 이용한 혈관성장인자 발현 줄기세포주
SG11201701655YA (en) 2014-09-19 2017-04-27 Agency Science Tech & Res Differentiation of hepatocyte-like cells from stem cells
CN107075471A (zh) 2014-10-08 2017-08-18 新加坡科技研究局 将干细胞分化为肝细胞谱系的方法
JP5777127B1 (ja) 2014-12-09 2015-09-09 公立大学法人横浜市立大学 原始腸内胚葉細胞及びその作製方法
US10590389B2 (en) 2014-12-24 2020-03-17 Kyoto University Endodermal cell production method, liver cell production method, pancreatic cell production method, endodermal cell induction promoter, liver cell induction promoting kit, pancreatic cell induction promoting kit, and microfluidic device
US10711249B2 (en) 2014-12-26 2020-07-14 Kyoto University Method for inducing hepatocytes
US10836997B2 (en) 2015-03-09 2020-11-17 Keio University Method for differentiating pluripotent stem cells into desired cell type
US20180147242A1 (en) 2015-03-18 2018-05-31 The University Of Tokyo Hepatocytes and hepatic non-parenchymal cells, and methods for preparation thereof
EP3280797A4 (en) 2015-04-10 2019-01-16 Agency For Science, Technology And Research GENERATION OF FUNCTIONAL CELLS FROM STEM CELLS
CA2988854A1 (en) 2015-05-08 2016-11-17 President And Fellows Of Harvard College Universal donor stem cells and related methods
US20180320186A1 (en) 2015-08-20 2018-11-08 Inter-University Research Institute Corporation Research Organization Of Information And Systems Method for site-specific insertion of foreign dna into a genome in an animal cell and a cell obtained using same
CN110582564A (zh) 2015-09-15 2019-12-17 新加坡科技研究局 从人类多能干细胞衍生肝类器官
EP3366687B1 (en) 2015-09-18 2020-04-29 National University Corporation Tottori University Suppression and regeneration promoting effect of low molecular weight compound on cancer and fibrosis
WO2017070145A1 (en) 2015-10-19 2017-04-27 Cellular Dynamics International, Inc. Production of virus-receptive pluripotent stem cell (psc)-derived hepatocytes
CN109715801B (zh) 2015-12-01 2022-11-01 克里斯普治疗股份公司 用于治疗α1抗胰蛋白酶缺乏的材料和方法
GB201521179D0 (en) 2015-12-01 2016-01-13 Univ Leuven Kath Methods for differentiating cells into hepatic stellate cells
MX2018007840A (es) 2015-12-23 2019-05-02 Crispr Therapeutics Ag Materiales y metodos para el tratamiento de la esclerosis lateral amiotrofica y/o la degeneracion lobar frontotemporal.
EP3397753B1 (en) 2015-12-30 2021-10-27 FUJIFILM Cellular Dynamics, Inc. Microtissue formation using stem cell-derived human hepatocytes
JP6792857B2 (ja) 2016-01-29 2020-12-02 国立大学法人千葉大学 肝細胞系譜細胞を取得するための方法および物質
US11396644B2 (en) 2016-01-31 2022-07-26 Keio University Method for promoting differentiation of pluripotent stem cells by reducing undifferentiated state thereof
EP3416689B1 (en) 2016-02-18 2023-01-18 CRISPR Therapeutics AG Materials and methods for treatment of severe combined immunodeficiency (scid) or omenn syndrome
GB201603569D0 (en) 2016-03-01 2016-04-13 Koninklijke Nederlandse Akademie Van Wetenschappen Improved differentiation method
US11083799B2 (en) 2016-03-16 2021-08-10 Crispr Therapeutics Ag Materials and methods for treatment of hereditary haemochromatosis
ITUA20162645A1 (it) 2016-04-15 2017-10-15 Ustem S R L Un nuovo metodo per la riprogrammazione cellulare
WO2018007871A1 (en) 2016-07-08 2018-01-11 Crispr Therapeutics Ag Materials and methods for treatment of transthyretin amyloidosis
CA3032920A1 (en) 2016-08-03 2018-02-08 Life Science Institute, Inc. Method for inducing differentiation of pluripotent stem cells in vitro
EP3515463A1 (en) 2016-09-26 2019-07-31 Boston Scientific Scimed, Inc. Mitochondrial epigenetic reprogramming and transplant
WO2018085623A1 (en) 2016-11-04 2018-05-11 Children's Hospital Medical Center Compositions and methods of treating liver disease
CA3043368A1 (en) 2016-11-16 2018-05-24 Allele Biotechnology & Pharmaceuticals, Inc. Induction of hepatocytes by stem cell differentiation with rna
GB201619876D0 (en) 2016-11-24 2017-01-11 Cambridge Entpr Ltd Controllable transcription
AU2018224380A1 (en) 2017-02-22 2019-08-29 Crispr Therapeutics Ag Compositions and methods for treatment of proprotein convertase subtilisin/kexin type 9 (PCSK9)-related disorders
US11136555B2 (en) 2017-03-01 2021-10-05 Elixirgen Scientific, Inc. Compositions and methods for differentiation of human pluripotent stem cells into desired cell types
WO2018227016A1 (en) 2017-06-07 2018-12-13 Wild Type, Inc. Ex vivo meat production
KR102625361B1 (ko) 2017-06-09 2024-01-18 칠드런즈 호스피탈 메디칼 센터 간 유사 장기 조성물 및 이를 제조 및 사용하는 방법
ES2991454T3 (es) 2017-06-16 2024-12-03 Univ Leuven Kath Medios de cultivo celular para diferenciar células madre en hepatocitos
US11530132B2 (en) 2017-09-05 2022-12-20 Lemonex Inc. Composition comprising porous silica particles carrying a cell fate modulating factor
EP3681520A4 (en) 2017-09-12 2021-07-07 Beth Israel Deaconess Medical Center, Inc. COMPOSITIONS AND METHODS FOR TREATING HEPATIC DISEASE AND HEPATIC DYSFUNCTION
JP7315150B2 (ja) 2017-10-12 2023-07-26 国立大学法人東京工業大学 多能性幹細胞から肝細胞への分化誘導方法
US20210096126A1 (en) 2017-12-21 2021-04-01 Children's Hospital Medical Center Digitalized human organoids and methods of using same
US11946069B2 (en) 2018-03-12 2024-04-02 RxCell, Inc. Method for generating multiple cellular products from single pluripotent cell source
WO2019213366A1 (en) 2018-05-02 2019-11-07 The Trustees Of Columbia University In The City Of New York Methods to induce terminal differentiation in stem cells by interfering with dna replication, methods of inducing pancreatic differentiation, and differentiated cells obtained thereof
CN112533618A (zh) 2018-05-16 2021-03-19 华盛顿大学 用于生成内胚层谱系细胞和β细胞的方法和组合物及其用途
US20210189350A1 (en) 2018-05-25 2021-06-24 Valorisation-Hsj, Limited Partnership Process for making cell populations of the hepatic lineage from endodermal cells and cellular compositions comprising same
WO2019237124A1 (en) 2018-06-09 2019-12-12 Arizona Board Of Regents On Behalf Of Arizona State University Next generation designer liver organoids and their methods of preparation and use
CA3103823A1 (en) 2018-06-14 2019-12-19 Figene, Llc Use of fibroblasts and/or modified fibroblasts for three dimensional tissue printing
AU2019339410A1 (en) 2018-09-12 2021-04-15 Children's Hospital Medical Center Organoid compositions for the production of hematopoietic stem cells and derivatives thereof
WO2020081716A2 (en) 2018-10-16 2020-04-23 Texas Tech University System Biomaterials for 3d cell growth and differentiation
WO2020139914A1 (en) 2018-12-26 2020-07-02 Academia Sinica Methods for regulating potency of pluripotent stem cells and applications thereof

Also Published As

Publication number Publication date
BR112022018092A2 (pt) 2022-11-22
US20210284960A1 (en) 2021-09-16
EP4118188A1 (en) 2023-01-18
KR20230010625A (ko) 2023-01-19
JP2023516484A (ja) 2023-04-19
US11274279B2 (en) 2022-03-15
CA3175071A1 (en) 2021-09-16
AU2021235252A1 (en) 2022-10-06
US20220235321A1 (en) 2022-07-28
CN115551994A (zh) 2022-12-30

Similar Documents

Publication Publication Date Title
EP4464793A3 (en) Methods for generating spatially barcoded arrays
ZA202310779B (en) Compositions and methods for enhanced gene expression
AU2016250905A8 (en) Generation of muscle-lineage cells from stem cells
GB2548740A (en) Methods for generation of podocytes from pluripotent stem cells and cells produced by the same
MX2022003477A (es) Medio de cultivo celular complementado con taurina y metodos de uso.
MX2019010039A (es) Composiciones y métodos para transducción de tumores.
WO2018097540A3 (ko) 무혈청면역세포배양용 배지첨가키트, 상기 키트를 이용한 면역세포배양방법, 상기 키트 또는 배양방법에 의해 얻어진 무혈청면역세포배양액 및 상기 배양액을 포함하는 화장료조성물
EP4446338A3 (en) Cells and method of cell culture
MX2019011778A (es) Composicion para producir tagatosa y procedimiento de produccion de tagatosa usando la misma.
MX375786B (es) Biosintesis microbiana de ergotioneina.
PH12019501001A1 (en) Method for preparing electrocompetent yeast cells, and method for using said cells
UA104927C2 (uk) Стабілізація руху нестійких фрагментів космічного сміття
MX2018015298A (es) Metodo para estabilizar proteinas.
SG10201809452RA (en) Cell culture compositions with antioxidants and methods for polypeptide production
EA201791275A1 (ru) Способы получения ctp-модифицированных полипептидов длительного действия
EP3827027A4 (en) COMPOSITION AND PROCESSES FOR GENERATION AND CONSERVATION OF MOLECULAR HYDROGEN (H2) IN AQUEOUS SYSTEMS
MX2018003678A (es) Metodos moleculares de aseguramiento de la calidad para su uso en la secuenciacion.
MX2021001528A (es) Metodo para la produccion de celulas positivas para cd3.
CL2019002797A1 (es) Preservantes para madera.
SG11201903254PA (en) Undifferentiated stem cell-removing agent, and method for removing undifferentiated stem cells
MX2020003143A (es) Biomaterial que comprende celulas germinales derivadas del tejido adiposo y metodo para su produccion.
WO2019224713A3 (en) Monospecific and multispecific anti-tmeff2 antibodies and there uses
EP4072570A4 (en) METHOD FOR GENERATING HEMATOPOETIC STEM CELLS
MX2021003219A (es) Biomaterial que comprende celulas germinales derivadas de tejido adiposo y gelatina y metodo para producir el mismo.
ZA202208613B (en) Methods for improving cell viability in a production bioreactor